Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$365M |
| 2 |
Global Payments
GPN
|
+$250M |
| 3 |
NiSource
NI
|
+$109M |
| 4 |
Constellation Brands
STZ
|
+$107M |
| 5 |
Xcel Energy
XEL
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$95.7M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$89.4M |
| 3 |
ExxonMobil
XOM
|
+$84.7M |
| 4 |
Southern Company
SO
|
+$79.2M |
| 5 |
Emerson Electric
EMR
|
+$61.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.26% |
| 2 | Industrials | 7.84% |
| 3 | Utilities | 7.6% |
| 4 | Healthcare | 5.4% |
| 5 | Real Estate | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Motorcar Parts of America
MPAA
$219M
| $255K | ﹤0.01% |
+27,348
| New | +$231K |
|
|
PVBC
1227
DELISTED
Provident Bancorp
PVBC
| $255K | ﹤0.01% |
+25,314
| New | +$245K |
|
1228
Southern California Bancorp
BCAL
$690M
| $251K | ﹤0.01% |
+14,468
| New | +$217K |
|
1229
PROG Holdings
PRG
$1.56B
| $251K | ﹤0.01% |
8,128
-9,562
| -54% | -$281K |
|
1230
Boise Cascade
BCC
$2.87B
| $249K | ﹤0.01% |
1,926
-10,448
| -84% | -$1.12M |
|
1231
Consensus Cloud Solutions
CCSI
$710M
| $249K | ﹤0.01% |
+9,518
| New | +$223K |
|
1232
Lantronix
LTRX
$256M
| $248K | ﹤0.01% |
+42,401
| New | +$213K |
|
1233
Weave Communications
WEAV
$583M
| $248K | ﹤0.01% |
+21,647
| New | +$192K |
|
1234
Hawthorn Bancshares
HWBK
$269M
| $247K | ﹤0.01% |
+9,755
| New | +$193K |
|
1235
Iris Energy
IREN
$14.2B
| $245K | ﹤0.01% |
34,283
+11,779
| +52% | +$50.6K |
|
1236
Bank of N.T. Butterfield & Son
NTB
$2.3B
| $244K | ﹤0.01% |
+7,628
| New | +$216K |
|
1237
Zeta Global
ZETA
$7.15B
| $242K | ﹤0.01% |
+27,401
| New | +$230K |
|
1238
PennantPark Floating Rate Capital
PFLT
$740M
| $240K | ﹤0.01% |
19,850
-872
| -4% | -$9.52K |
|
1239
Kornit Digital
KRNT
$707M
| $238K | ﹤0.01% |
+12,407
| New | +$215K |
|
1240
National Beverage
FIZZ
$3.1B
| $236K | ﹤0.01% |
4,739
-18,577
| -80% | -$889K |
|
1241
DLH Holdings
DLHC
$65.4M
| $235K | ﹤0.01% |
+14,915
| New | +$209K |
|
1242
Vestis
VSTS
$1.69B
| $235K | ﹤0.01% |
+11,099
| New | +$190K |
|
|
ML
1243
DELISTED
MoneyLion Inc.
ML
| $233K | ﹤0.01% |
+3,723
| New | +$125K |
|
1244
GeoPark
GPRK
$639M
| $231K | ﹤0.01% |
+26,950
| New | +$255K |
|
1245
Puma Biotechnology
PBYI
$471M
| $231K | ﹤0.01% |
+53,240
| New | +$176K |
|
1246
Mesa Laboratories
MLAB
$696M
| $230K | ﹤0.01% |
+2,200
| New | +$214K |
|
1247
Zillow
ZG
$8.53B
| $230K | ﹤0.01% |
+4,053
| New | +$174K |
|
|
VSTO
1248
DELISTED
Vista Outdoor Inc.
VSTO
| $230K | ﹤0.01% |
7,782
-33,592
| -81% | -$924K |
|
1249
OP Bancorp
OPBK
$229M
| $229K | ﹤0.01% |
+20,932
| New | +$192K |
|
1250
Rimini Street
RMNI
$485M
| $229K | ﹤0.01% |
+70,085
| New | +$193K |
|
Similar funds
Michael Gelband's Q4 2023 Portfolio in Review
As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.
On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.
- Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
- Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
- Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
- Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
- Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
- Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
- Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.